Previous 10 | Next 10 |
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is one of today's top gainers. The company's shares are currently up 1.56% on the day to $838.13. Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The...
2023-09-08 09:53:00 ET September has historically been the worst month for the S&P 500 , a phenomenon called the "September effect." The next few weeks may or may not live up (or down) to these low expectations, but investors need not worry about any short-term blip. Whether the mar...
2023-09-06 13:46:05 ET Regeneron Pharmaceuticals, Inc. (REGN) 2023 Wells Fargo Healthcare Conference Transcript September 6, 2023, 8:45 AM ET Executives Marion McCourt - Head, Commercial Ryan Crowe - Head, Investor Relations Analysts Mohit Bansal - Wells ...
2023-09-05 10:15:00 ET In mid-August, Novartis (NYSE: NVS) shared positive results from the phase 3 clinical trial of its biosimilar to Regeneron (NASDAQ: REGN) and Bayer AG 's (OTC: BAYR.Y) Eylea. The Swiss drugmaker's results from the phase 3 clinical trial of its ...
2023-09-02 14:00:00 ET More on pharma companies Eli Lilly And Novo Nordisk: Are Weight Loss Drugs A Global Revolution Or Short-Lived Fad? Novo Nordisk: Super Focused Pharma Company For The Long Run Regeneron Gets Boost With FDA Approval Of High-Dose Eylea (Rati...
2023-08-23 14:46:51 ET Summary 14-week data from the phase 2 LUNA study, using Ixo-vec for the treatment of patients with wet age-related macular degeneration, expected in late Q3 of 2023. Preliminary safety and efficacy data from phase 2 LUNA study, using Ixo-vec for the treatmen...
2023-08-23 02:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-08-22 15:20:41 ET More on Regeneron Pharmaceuticals Regeneron Gets Boost With FDA Approval Of High-Dose Eylea (Rating Upgrade) Regeneron Pharmaceuticals Inc. ( REGN ) Q2 2023 Earnings Call Transcript Regeneron: CRL For High Dose Eylea Gives Vabysmo A Wider O...
2023-08-22 14:52:24 ET More on Regeneron, Johnson & Johnson Regeneron Gets Boost With FDA Approval Of High-Dose Eylea (Rating Upgrade) Johnson & Johnson Vs. Kenvue: The Better Dividend Aristocrat Might Shock You ICON: Economic Business Returns Lagging Capital...
TARRYTOWN, N.Y., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that the Biomedical Advanced Research and Development Authority (BARDA) has entered into an agreement with Regeneron to support clinical development, clinical manufacturing and t...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...